| Alteplase ThromboLysis for Acute Noninterventional Therapy in Ischemic Stroke |
ATLANTIS |
3 |
 |
| European and Australian Cooperative Stroke Study II |
ECASS-II |
3 |
|
| NINDS t-PA Stroke Trial |
NINDS-tPA |
3 |
|
| European Cooperative Acute Stroke Study |
ECASS-I |
3 |
|
| Emergency Management of Stroke Bridging Trial |
EMS |
N/A |
|
| Third International Stroke Trial |
IST-3 |
3 |
 |
| Intraventricular Hemorrhage Thrombolysis Trial |
ITT |
2 |
|
| Canadian Activase for Stroke Effectiveness Study |
CASES |
4 |
|
| Thrombolytic Therapy in Acute Ischemic Stroke Study, Part A |
TTAISS |
2 |
|
| Standard Treatment with Alteplase to Reverse Stroke study |
STARS |
N/A |
|
| Prevention of delayed ischemic deficits after aneurysmal subarachnoid hemorrhage by intrathecal bolus injection of tissue plasminogen activator |
|
N/A |
|
| Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Register |
SITS-ISTR |
N/A |
 |
| Interventional Management of Stroke (IMS) Study |
|
2 |
|
| A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) |
|
2 |
|
| Intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm |
|
N/A |
|
| Safe Implementation of Thrombolysis in Stroke Monitoring Study |
SITS-MOST |
N/A |
|
| Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke |
|
N/A |
|
| Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) |
|
2 |
|
| Combined Lysis of Thrombus in Brain ischemia with Transcranial Ultrasound and Systemic TPA [SPOTRIAS] |
CLOTBUST Phase I |
N/A |
|
| Combined Lysis of Thrombus in Brain Ischemia with Transcranial Ultrasound and Systemic TPA [SPOTRIAS] |
CLOTBUST Phase II |
N/A |
|
| Rt-PA in the Treatment of Acute Ischemic Stroke |
|
3 |
|
| Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial |
|
1/2 |
|
| Abciximab and rt-PA in Acute Ischemic Stroke Treatment |
|
N/A |
|
| Interventional Management of Stroke Study |
IMS - II |
N/A |
|
| Transcranial Low-Frequency Ultrasound Mediated Thrombolysis in Brain Ischemia Study |
TRUMBI |
N/A |
|
| Perfusion-CT guided intravenous thrombolysis at 3 to 6 hours: feasibility and safety study |
|
N/A |
|
| Argatroban TPA Stroke Study |
|
1/2 |
|
| Albumin in Acute Stroke |
ALIAS - Pilot |
N/A |
|
| Dutch Intraventricular Thrombolysis after Cerebral Hemorrhage study |
DITCH |
N/A |
|
| Diffusion-weighted Imaging Evaluation For Understanding Stroke Evolution |
DEFUSE |
N/A |
|
| Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage |
CLEAR IVH |
2 |
|
| Echoplanar Imaging Thrombolysis Evaluation - Pilot Study |
EPITHET - Pilot |
N/A |
|
| Urokinase versus r-TPA in Stroke Patients |
|
N/A |
|
| Multi MERCI (Mechanical Embolus Removal in Cerebral Ischemia [MERCI™]) |
Multi MERCI |
N/A |
|
| Imaging-based Thrombolysis Trial in Acute Ischemic Stroke |
ITAIS |
N/A |
|
| Clinical importance of microbleeds in patients receiving IV thrombolysis |
|
N/A |
|
| Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B) |
|
2 |
|
| Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion |
|
3 |
|
| Interventional Management of Stroke (IMS) III Trial |
IMSIII |
3 |
|
| Comparison of Intra-arterial and Intravenous Thrombolysis for Ischemic Stroke with Hyperdense Middle Cerebral Artery Sign |
|
N/A |
|
| TRUST-tPA: Therapeutic Trial Evaluating Efficacy of Telemedicine (TELESTROKE) of Patients With Acute Stroke |
|
4 |
|
| Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke |
|
1 |
|
| Study of Aspirin and TPA in Acute Ischemic Stroke |
|
1 |
 |
| Safety and Efficacy of MRI-Based Thrombolysis in Unclear-Onset Stroke |
|
N/A |
|
| Cooling in acute Stroke-II |
COAST-II |
N/A |
|
| Imaging-based Thrombolysis trial in Acute Ischemic Stroke-II |
ITAIS-II |
N/A |
|
| Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke |
CLEAR-ER |
2 |
|
| STroke imAging pRevention and Treatment-Extending the time for Thrombolysis in Emergency
Neurological Deficits
|
START-EXTEND |
N/A |
|
| Extending the Time for Thrombolysis in Emergency Neurological Deficits |
EXTEND |
3 |
|
| Antiplatelet therapy in combination with Recombinant t-PA Thrombolysis in Ischemic Stroke. |
ARTIS |
N/A |
|
| Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis |
ATTRACT |
3 |
|
| Safety of Lysis with EKOS Ultrasound in the Treatment of Intracerebral and Intraventricular Hemorrhage |
SLEUTH |
N/A |
|
| Thrombolysis in Elderly Stroke Patients in Italy
|
TESPI |
N/A |
|
| BIOLOGICAL MARKERS AS PREDICTORS OF CLINICAL-FUNCTIONAL OUTCOME AND RESPONSE TO REVASCULARIZATION STRATEGIES IN ACUTE ISCHEMIC STROKE |
MAGIC |
N/A |
|
| A Randomized, Active Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization (CLOTBUSTER) in Acute Ischemic Stroke |
CLOTBUSTER |
3 |
|
| Hypothermia in Acute Ischemic Stroke - Surface versus Endovascular cooling |
HAIS-SE |
N/A |
|
